Title

Proteasome inhibitor for treatment of multiple myeloma

Document Type

Article

Department

Ophthalmology

Abstract

Bortezomib is more effective than high-dose dexamethasone for treatment of patients with relapsed multiple myeloma, according to results from the Assessment of Proteasome Inhibition for Extending Remissions

Publication

lancet oncology